Treatment of Lower Urinary Tract Symptoms and Risk of Prostate Cancer Mortality: Kaiser Permanente Multi-Region Study (2014-2015)

You are here

Funded by Kaiser Permanente Research Foundation Institute

Funding Years: 2014 - 2015.

This retrospective cohort study will assess the association of BPH treatment (5ARI and alpha-blocker medications) with the occurrence of prostate cancer related mortality. An electronic algorithm for classifying prostate cancer related deaths will be created and validated using medical records. This study will also assess a number of secondary endpoints including the occurrence of prostate cancer and metastatic prostate cancer, cardiovascular and all cause mortality.

PI(s): Sarah Hawley, Lauren Wallner (Sponsor PI)